Other Species / Isoforms
  ROMK (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S4
____MGASERSVFRV
2 0
ROMK (human) ____MNAsSRNVFDT S4-p
ROMK (mouse) gap -
ROMK (rat) ____MGASERSVFRV S4
ROMK iso2 (rat) gap -
S44-p
RQRARLVsKEGRCNI
Upstream
Downstream
9 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • protein conformation
Putative in vivo kinases:
  • PKACA (human)
  • SGK1 (rat)
Treatment
  • colforsin
  • gabapentin
  • H-89
  • HGF
  • IBMX
  • KT5720
ROMK (human) RQRARLVsKDGRCNI S44-p
ROMK (mouse) RQRARLVsKDGRCNI S25-p
ROMK (rat) RQRARLVsKEGRCNI S44-p
ROMK iso2 (rat) RQRARLVsKEGRCNI S25-p
N117
PEFYPPDNRTPCVEN
0 1
ROMK (human) PEFHPSANHTPCVEN N117
ROMK (mouse) PEFYPPDnRTPCVEN N98-ng
ROMK (rat) PEFYPPDNRTPCVEN N117
ROMK iso2 (rat) PEFYPPDNRTPCVEN N98
S183
GAILAKISRPKKRAK
2 0
ROMK (human) GAILAKIsRPKKRAK S183-p
ROMK (mouse) GAILAKISRPKKRAK S164
ROMK (rat) GAILAKISRPKKRAK S183
ROMK iso2 (rat) GAILAKISRPKKRAK S164
T191
RPKKRAKTITFSKNA
2 0
ROMK (human) RPKKRAKtItFSKNA T191-p
ROMK (mouse) RPKKRAKTITFSKNA T172
ROMK (rat) RPKKRAKTITFSKNA T191
ROMK iso2 (rat) RPKKRAKTITFSKNA T172
T193
KKRAKTITFSKNAVI
2 0
ROMK (human) KKRAKtItFSKNAVI T193-p
ROMK (mouse) KKRAKTITFSKNAVI T174
ROMK (rat) KKRAKTITFSKNAVI T193
ROMK iso2 (rat) KKRAKTITFSKNAVI T174
S201
FSKNAVISKRGGKLC
3 1
ROMK (human) FSKNAVIskRGGKLC S201-p
ROMK (mouse) FSKNAVIsKRGGKLC S182-p
ROMK (rat) FSKNAVISKRGGKLC S201
ROMK iso2 (rat) FSKNAVISKRGGKLC S182
K202
SKNAVISKRGGKLCL
0 1
ROMK (human) SKNAVIskRGGKLCL K202-ac
ROMK (mouse) SKNAVIsKRGGKLCL K183
ROMK (rat) SKNAVISKRGGKLCL K202
ROMK iso2 (rat) SKNAVISKRGGKLCL K183
S219-p
RVANLRKsLLIGSHI
Upstream
Downstream
5 0
Effects on Modified Protein
  • activity, induced
  • protein conformation
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • colforsin
  • gabapentin
  • H-89
  • IBMX
  • KT5720
ROMK (human) RVANLRKsLLIGSHI S219-p
ROMK (mouse) RVANLRKSLLIGSHI S200
ROMK (rat) RVANLRKsLLIGSHI S219-p
ROMK iso2 (rat) RVANLRKsLLIGSHI S200-p
T234
YGKLLKTTITPEGET
1 0
ROMK (human) YGKLLKTtVTPEGET T234-p
ROMK (mouse) YGKLLKTTITPEGET T215
ROMK (rat) YGKLLKTTITPEGET T234
ROMK iso2 (rat) YGKLLKTTITPEGET T215
S313-p
ATCQVRTsYVPEEVL
Upstream
Downstream
5 0
Effects on Modified Protein
  • activity, induced
  • protein conformation
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • colforsin
  • gabapentin
  • H-89
  • IBMX
  • KT5720
ROMK (human) ATCQVRTsYVPEEVL S313-p
ROMK (mouse) ATCQVRTSYIPEEVL S294
ROMK (rat) ATCQVRTsYVPEEVL S313-p
ROMK iso2 (rat) ATCQVRTsYVPEEVL S294-p
K331
RFVPIVSKTKEGKYR
0 1
ROMK (human) RFAPIVSKTKEGKyR K331
ROMK (mouse) RFVPIVSkTKEGKYR K312-ub
ROMK (rat) RFVPIVSKTKEGKYR K331
ROMK iso2 (rat) RFVPIVSKTKEGKYR K312
Y337
SKTKEGKYRVDFHNF
4 0
ROMK (human) SKTKEGKyRVDFHNF Y337-p
ROMK (mouse) SkTKEGKYRVDFHNF Y318
ROMK (rat) SKTKEGKYRVDFHNF Y337
ROMK iso2 (rat) SKTKEGKYRVDFHNF Y318
K363
AMCLYNEKDARARMK
0 1
ROMK (human) AMCLYNEKDVRARMK K363
ROMK (mouse) AMCLYNEkDARARMK K344-ub
ROMK (rat) AMCLYNEKDARARMK K363
ROMK iso2 (rat) AMCLYNEKDARARMK K344